This paper was published in Chest 2008 Oct;134(4):824-30
Study title and authors:
Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports.
Study title and authors:
Statins and interstitial lung disease: a systematic review of the literature and of food and drug administration adverse event reports.
Fernández AB, Karas RH, Alsheikh-Ali AA, Thompson PD.
Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/18689579
Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/18689579
This study reviewed the scientific literature to examine the relationship between statins and interstitial lung disease. (Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis).
After reviewing evidence from the previous 20 years the researchers concluded: "Statin-induced interstitial lung disease is a possible newly recognized side effect of statin therapy".
